Product fact sheet
MitoPRO 300+: Technical Specifications & Independent Lab Data
Source-backed MitoPRO 300+ hardware facts, including current manufacturer specifications and LightLab wall draw, radiant power and six-inch irradiance measurements.
A compact four-wavelength MitoPRO+ panel with current manufacturer specifications and a LightLab ISO/IEC 17025 hardware report for the tested 300+ v2 sample.
targeted panel comparisons with third-party radiometric data, buyers comparing wall draw with optical radiant power
anyone treating one tested sample as proof of clinical efficacy, buyers who need Homeapotherapy hands-on testing
Key tradeoff: Independent output data is unusually detailed, but it remains hardware testing of a submitted sample rather than a clinical comparison or Homeapotherapy measurement.
This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.
The MitoPRO 300+ is a compact four-wavelength panel. Its current manufacturer page provides physical and electrical specifications, while Mito’s independent-test index reproduces LightLab International measurements for the tested MitoPRO 300+ v2 sample.
Why the two power numbers differ
The manufacturer lists 90 W power consumption. LightLab measured 96.6 W wall draw for the submitted test sample. LightLab also measured 34.3 W total radiant power. Those three figures describe different things and should not be substituted for one another.
What the independent report adds
At six inches, under LightLab’s stated Area Below LEDs geometry and 380–1000 nm measurement context, the tested sample recorded 41.8 mW/cm² average irradiance and 60.1 mW/cm² peak irradiance. These are laboratory hardware measurements, not Homeapotherapy measurements and not evidence that the device produces better clinical outcomes than another panel.
What remains unknown
Homeapotherapy has not repeated the protocol, measured acoustic or thermal behavior, or tested this device head-to-head with other panels under one common protocol. Future hardware revisions should be matched to the correct report generation rather than assumed equivalent.
For help interpreting irradiance, radiant power, LED count and wavelength lists, see Red Light Device Specifications Explained.
Technical specifications
Published specs and what they mean
Physical
- Panel dimensions
- 10 × 12 in (W × H; panel only) Basis: Manufacturer published Current manufacturer comparison table. Source: MitoPRO+ Red Light Therapy Panels
- Weight
- 10 lb Basis: Manufacturer published Current manufacturer comparison table. Source: MitoPRO+ Red Light Therapy Panels
Optical
- Published wavelengths
- 630 / 660 / 830 / 850 nm Basis: Manufacturer published Current manufacturer comparison table. Source: MitoPRO+ Red Light Therapy Panels
- LED count
- 60 LEDs Basis: Manufacturer published Current manufacturer comparison table. Source: MitoPRO+ Red Light Therapy Panels
- Measured total radiant power
- 34.3 W Basis: Independent lab Conditions: LightLab International ISO/IEC 17025-accredited measurement; 380–1000 nm spectral data; report LLIA002765-003. LightLab report LLIA002765-003. Source: Independent ISO/IEC 17025 Panel Test Data (HTML data index)
- Average irradiance at 6 in
- 41.8 mW/cm² Basis: Independent lab Conditions: Six inches; Area Below LEDs spatial averaging; 380–1000 nm; report LLIA002765-003. LightLab spatial average for the tested sample. Source: Independent ISO/IEC 17025 Panel Test Data (HTML data index)
- Peak irradiance at 6 in
- 60.1 mW/cm² Basis: Independent lab Conditions: Six inches; 380–1000 nm; report LLIA002765-003. LightLab peak for the tested sample. Source: Independent ISO/IEC 17025 Panel Test Data (HTML data index)
Electrical
- Published power consumption
- 90 W Basis: Manufacturer published Current manufacturer comparison table. Source: MitoPRO+ Red Light Therapy Panels
- Measured wall draw
- 96.6 W Basis: Independent lab Conditions: LightLab International; six-inch device distance; Area Below LEDs geometry; report LLIA002765-003. LightLab report LLIA002765-003; tested 2025-09-11. Source: Independent ISO/IEC 17025 Panel Test Data (HTML data index)
What the current record does not establish
- Homeapotherapy has not independently repeated the LightLab test protocol.
- The current retail family page and LightLab report naming should be checked by generation when a future hardware revision is released.
- No product-level clinical superiority claim is established by the hardware report.
A missing field is not evidence that the device lacks the feature or performs poorly. It means we do not currently have a sufficiently comparable, sourced value in the normalized record.
Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.
Dose and irradiance context
What the output number means over time
Fluence is a calculation, not a treatment recommendation. For continuous output, fluence in J/cm² equals irradiance in mW/cm² × seconds ÷ 1000. The calculation only remains meaningful at the measurement conditions used for the irradiance value.
Neutral conversion from the independent average measurement
Normalized measured average: 41.8 mW/cm².
Measurement conditions: Six inches; Area Below LEDs spatial averaging; 380–1000 nm; report LLIA002765-003.
- 1 minute
- 2.51 J/cm²
- 5 minutes
- 12.54 J/cm²
- 10 minutes
- 25.08 J/cm²
- 20 minutes
- 50.16 J/cm²
These figures are arithmetic translations of one independently measured area-average irradiance. They are not suggested session lengths, target fluences or evidence that the same irradiance reaches tissue at a different distance, body contour, device mode or treatment geometry.
What this calculation still cannot tell you
- whether this is an effective dose for any condition;
- how irradiance changes at a different distance or across curved anatomy;
- how much energy reaches tissue below the surface;
- whether a study used the same wavelength distribution, spot size, pulse mode or treatment schedule;
- whether peak irradiance would produce the same area exposure as the average value shown here.
Read Red Light Irradiance, Fluence and Dose Explained before trying to compare this output with a clinical paper or another panel.
Clinical evidence context
Where these wavelengths overlap with human research
Published device wavelengths: 630 / 660 / 830 / 850 nm.
This is a hardware-to-literature cross-reference, not a claim that this product treats any condition. A matching nominal wavelength does not reproduce a study's irradiance, dose, distance, treatment area, emitter geometry, schedule or patient population.
Research areas worth checking
- Pattern hair loss — human studies commonly use visible-red wavelengths, especially around the mid-600 nm range.
- Acne and inflammatory skin — red-light protocols exist, but acne studies may also use blue light and should not be generalized from panel specs.
- Skin rejuvenation and photoaging — visible-red and red/NIR LED protocols have been studied with varied devices and endpoints.
- Knee osteoarthritis — near-infrared wavelengths appear in the clinical literature, but wavelength alone does not establish an equivalent treatment protocol.
- Muscle recovery and musculoskeletal pain — research spans red and near-infrared bands with substantial protocol variation.
- Transcranial PBM and cognition — some research uses near-infrared wavelengths, but a body panel is not automatically equivalent to a head-targeted transcranial device.
- See the full wavelength-by-condition evidence chart for evidence strength, treatment geometry and major caveats.
Do not infer from wavelength overlap
- that this device is clinically proven for the linked condition;
- that more wavelengths are better;
- that the highest published irradiance is the best dose;
- that an open wound should be treated with a consumer device without appropriate wound assessment.
For wounds specifically, start with the wound-care safety decision guide before interpreting any device specification.
Safety first
What should make you slow down?
Use the product as directed, avoid treating concentrated wellness products as automatically harmless, and ask a qualified clinician when your situation or medication use makes the decision less routine.
Where to buy
Current tracked merchants
Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.
No merchant destination is currently tracked for this product.
Source trail
Primary documents and supporting evidence
- MitoPRO+ Red Light Therapy PanelsMito Red Light · Manufacturer · retrieved 2026-08-11
- Independent ISO/IEC 17025 Panel Test DataMito Red Light / LightLab International · Independent lab · HTML data index · retrieved 2026-08-11